Gladstone Institutes
NEWS
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 8, 2020.
The focus of the research will be to learn more about ApoE4 and how and why it affects Alzheimer’s disease.
Here are some of the top research stories that happened around the industry this week.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Robert Mahley, founder and president of Gladstone Institutes, an internationally-recognized expert on heart disease, cholesterol metabolism and Alzheimer’s disease, is launching a biotech company to focus on Alzheimer’s disease. The company is called GABAeron.
New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.
CRISPR pioneer Jennifer Doudna has set up shop in San Francisco’s Gladstone Institutes. Doudna, a UC Berkley professor credited with the co-discovery of CRISPR-Cas9 genome editing technique, will focus on the development of new ways to implement the gene-editing technique for disease treatment.
JOBS
IN THE PRESS